{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:07:20Z","timestamp":1791342440188,"version":"4.3.1"},"reference-count":40,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The pace of resistance against antibiotics almost exceeds that of the development of new drugs. As many bacteria have become resistant to conventional antibiotics, new drugs or drug resources are badly needed to combat antibiotic-resistant pathogens, like methicillin-resistant\n            <jats:italic>Staphylococcus aureus<\/jats:italic>\n            (MRSA). Antimicrobial peptides, rich sources existing in nature, are able to effectively kill multidrug-resistant pathogens. Here, imcroporin, a new antimicrobial peptide, was screened and isolated from the cDNA library of the venomous gland of\n            <jats:italic>Isometrus maculates<\/jats:italic>\n            . The MIC of imcroporin against MRSA was 50 \u03bcg\/ml, 8-fold lower than that of cefotaxime and 40-fold lower than that of penicillin. Imcroporin killed bacteria rapidly in vitro, inhibited bacterial growth, and cured infected mice. These results revealed that imcroporin could be considered a potential anti-infective drug or lead compound, especially for treating antibiotic-resistant pathogens.\n          <\/jats:p>","DOI":"10.1128\/aac.01436-08","type":"journal-article","created":{"date-parts":[[2009,5,19]],"date-time":"2009-05-19T01:29:54Z","timestamp":1242696594000},"page":"3472-3477","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":82,"title":["Imcroporin, a New Cationic Antimicrobial Peptide from the Venom of the Scorpion\n            <i>Isometrus maculates<\/i>"],"prefix":"10.1128","volume":"53","author":[{"given":"Zhenhuan","family":"Zhao","sequence":"first","affiliation":[{"name":"State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibao","family":"Ma","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Dai","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiming","family":"Zhao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SongRyong","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingliang","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Cao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"16","volume":"12","year":"2006","unstructured":"Appelbaum, P. C. 2006. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin. Microbiol. Infect.12(Suppl. 1):16-23.","journal-title":"Clin. Microbiol. Infect."},{"key":"e_1_3_2_3_2","first-page":"3","volume":"12","year":"2006","unstructured":"Appelbaum, P. C. 2006. MRSA\u2014the tip of the iceberg. Clin. Microbiol. Infect.12(Suppl. 2):3-10.","journal-title":"Clin. Microbiol. Infect."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2007.07.011"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.bmt.1704821","volume":"35","year":"2005","unstructured":"Avery, R., M. Kalaycio, B. Pohlman, R. Sobecks, E. Kuczkowski, S. Andresen, S. Mossad, J. Shamp, J. Curtis, J. Kosar, K. Sands, M. Serafin, and B. Bolwell. 2005. Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course. Bone Marrow Transplant.35:497-499.","journal-title":"Bone Marrow Transplant."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200317040-00002"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2005.11.004"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2004.0124.x"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M413406200"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/bbrc.1993.1778","volume":"194","year":"1993","unstructured":"Cociancich, S., M. Goyffon, F. Bontems, P. Bulet, F. Bouet, A. Menez, and J. Hoffmann. 1993. Purification and characterization of a scorpion defensin, a 4-kDa antibacterial peptide presenting structural similarities with insect defensins and scorpion toxins. Biochem. Biophys. Res. Commun.194:17-22.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-5793(00)01384-3","volume":"471","year":"2000","unstructured":"Conde, R., F. Z. Zamudio, M. H. Rodriguez, and L. D. Possani. 2000. Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom. FEBS Lett.471:165-168.","journal-title":"FEBS Lett."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1042\/bj3590035","volume":"359","year":"2001","unstructured":"Corzo, G., P. Escoubas, E. Villegas, K. J. Barnham, W. He, R. S. Norton, and T. Nakajima. 2001. Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator. Biochem. J.359:35-45.","journal-title":"Biochem. J."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00542-08"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0006-291X(02)00423-0","volume":"293","year":"2002","unstructured":"Dai, L., G. Corzo, H. Naoki, M. Andriantsiferana, and T. Nakajima. 2002. Purification, structure-function analysis, and molecular characterization of novel linear peptides from scorpion Opisthacanthus madagascariensis. Biochem. Biophys. Res. Commun.293:1514-1522.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1006\/bbrc.2001.5472","volume":"286","year":"2001","unstructured":"Dai, L., A. Yasuda, H. Naoki, G. Corzo, M. Andriantsiferana, and T. Nakajima. 2001. IsCT, a novel cytotoxic linear peptide from scorpion Opisthacanthus madagascariensis. Biochem. Biophys. Res. Commun.286:820-825.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.47.29537"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btm068"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.8.2086-2092.2000"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/7.2.157"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/02713680590968637"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-842X(00)01823-0"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-7799(97)01156-6"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1267"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.16.8856"},{"key":"e_1_3_2_25_2","first-page":"357","volume":"1778","year":"2007","unstructured":"Hoskin, D. W., and A. Ramamoorthy. 2007. Studies on anticancer activities of antimicrobial peptides. Biochim. Biophys. Acta1778:357-375.","journal-title":"Biochim. Biophys. Acta"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D592"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00056-05"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1312.070629"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.bbrc.2004.08.144","volume":"323","year":"2004","unstructured":"Lee, K., S. Y. Shin, K. Kim, S. S. Lim, K. S. Hahm, and Y. Kim. 2004. Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs. Biochem. Biophys. Res. Commun.323:712-719.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2007.06.008"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1033.2002.03177.x"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-007-6475-6"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.regpep.2005.01.015","volume":"129","year":"2005","unstructured":"Pal, T., A. Sonnevend, S. Galadari, and J. M. Conlon. 2005. Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2. Regul. Pept.129:85-91.","journal-title":"Regul. Pept."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.2174\/138920106777950771"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.7705\/biomedica.v25i4.1384","volume":"25","year":"2005","unstructured":"Rodriguez, C. A., and O. Vesga. 2005. Vancomycin-resistant Staphylococcus aureus. Biomedica25:575-587.","journal-title":"Biomedica"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1046\/j.1432-1327.2000.01556.x","volume":"267","year":"2000","unstructured":"Torres-Larios, A., G. B. Gurrola, F. Z. Zamudio, and L. D. Possani. 2000. Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus. Eur. J. Biochem.267:5023-5031.","journal-title":"Eur. J. Biochem."},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-1-4615-0059-9_26","volume":"531","year":"2003","unstructured":"Verhoef, J. 2003. Antibiotic resistance: the pandemic. Adv. Exp. Med. Biol.531:301-313.","journal-title":"Adv. Exp. Med. Biol."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe020106"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/415389a"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.peptides.2003.12.003","volume":"25","year":"2004","unstructured":"Zeng, X. C., S. X. Wang, Y. Zhu, S. Y. Zhu, and W. X. Li. 2004. Identification and functional characterization of novel scorpion venom peptides with no disulfide bridge from Buthus martensii Karsch. Peptides25:143-150.","journal-title":"Peptides"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0014-5793(99)01101-1","volume":"457","year":"1999","unstructured":"Zhu, S., W. Li, X. Zeng, D. Jiang, X. Mao, and H. Liu. 1999. Molecular cloning and sequencing of two \u201cshort chain\u201d and two \u201clong chain\u201d K+ channel-blocking peptides from the Chinese scorpion Buthus martensii Karsch. FEBS Lett.457:509-514.","journal-title":"FEBS Lett."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01436-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01436-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:17:23Z","timestamp":1645474643000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01436-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1128\/AAC.01436-08"],"URL":"https:\/\/doi.org\/10.1128\/aac.01436-08","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"2008-10-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-05-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}